Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2019 | 1 |
2020 | 2 |
2021 | 2 |
2022 | 1 |
2023 | 1 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials.
Lancet. 2015 Aug 8;386(9993):541-51. doi: 10.1016/S0140-6736(15)60125-8. Epub 2015 Jun 10.
Lancet. 2015.
PMID: 26072109
Clinical Trial.
Non-alcoholic fatty liver disease in patients with psoriasis: therapeutic implications.
Klujszo EH, Parcheta P, Witkowska AB, Krecisz B.
Klujszo EH, et al.
Postepy Dermatol Alergol. 2020 Aug;37(4):468-474. doi: 10.5114/ada.2019.83983. Epub 2019 Jul 25.
Postepy Dermatol Alergol. 2020.
PMID: 32994765
Free PMC article.
Review.
Item in Clipboard
Risankizumab Therapy for Moderate-to-Severe Psoriasis-A Multi-Center, Long-Term, Real-Life Study from Poland.
Adamczyk M, Bartosińska J, Raczkiewicz D, Adamska K, Adamski Z, Czubek M, Kręcisz B, Kłujszo E, Lesiak A, Narbutt J, Noweta M, Owczarczyk-Saczonek A, Owczarek W, Reich A, Samotij D, Siekierko A, Szczęch J, Walecka I, Ciechanowicz P, Woźniacka A, Liszewska A, Krasowska D.
Adamczyk M, et al. Among authors: klujszo e.
J Clin Med. 2023 Feb 20;12(4):1675. doi: 10.3390/jcm12041675.
J Clin Med. 2023.
PMID: 36836209
Free PMC article.
Item in Clipboard
Safety of therapies using ustekinumab in patients with psoriasis who have had hepatitis B virus infection.
Kłujszo EH, Zarębska-Michaluk D, Kręcisz B, Witkowska A.
Kłujszo EH, et al.
Dermatol Ther. 2022 Mar;35(3):e15274. doi: 10.1111/dth.15274. Epub 2021 Dec 28.
Dermatol Ther. 2022.
PMID: 34921578
Item in Clipboard
Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
Mahil SK, Dand N, Mason KJ, Yiu ZZN, Tsakok T, Meynell F, Coker B, McAteer H, Moorhead L, Mackenzie T, Rossi MT, Rivera R, Mahe E, Carugno A, Magnano M, Rech G, Balogh EA, Feldman SR, De La Cruz C, Choon SE, Naldi L, Lambert J, Spuls P, Jullien D, Bachelez H, McMahon DE, Freeman EE, Gisondi P, Puig L, Warren RB, Di Meglio P, Langan SM, Capon F, Griffiths CEM, Barker JN, Smith CH; PsoProtect study group.
Mahil SK, et al.
J Allergy Clin Immunol. 2021 Jan;147(1):60-71. doi: 10.1016/j.jaci.2020.10.007. Epub 2020 Oct 16.
J Allergy Clin Immunol. 2021.
PMID: 33075408
Free PMC article.
Clinical Trial.
Item in Clipboard
Dermatologic adverse events of protease inhibitor-based combination therapy in patients with chronic hepatitis C.
Kłujszo E, Parcheta P, Zarębska-Michaluk D, Ochwanowska E, Witkowska A, Rakowska A, Rudnicka L, Kryczka W.
Kłujszo E, et al.
J Dermatol Case Rep. 2014 Dec 31;8(4):95-102. doi: 10.3315/jdcr.2014.1183. eCollection 2014 Dec 31.
J Dermatol Case Rep. 2014.
PMID: 25621089
Free PMC article.
Item in Clipboard
A Randomized, Double-blind, Phase III Study Assessing Clinical Similarity of SB17 (Proposed Ustekinumab Biosimilar) to Reference Ustekinumab in Subjects with Moderate to Severe Plaque Psoriasis.
Feldman SR, Narbutt J, Girolomoni G, Brzezicki J, Reznichenko N, Zegadlo-Mylik MA, Pulka G, Dmowska-Stecewicz M, Kłujszo E, Rekalov D, Rajzer L, Lee J, Lee M, Rho YH.
Feldman SR, et al. Among authors: klujszo e.
J Am Acad Dermatol. 2024 Apr 27:S0190-9622(24)00663-7. doi: 10.1016/j.jaad.2024.04.045. Online ahead of print.
J Am Acad Dermatol. 2024.
PMID: 38685404
Item in Clipboard
Cite
Cite